The case isn’t going anywhere, legally speaking. Continue Reading at WCNC »Īn op-ed by Noah Feldman: A lawsuit in Texas is challenging a hospital’s requirement that its employees get vaccinated against Covid-19 before returning to work. HHS has a list of what information is protected on its website. While HIPAA rules apply to covered entities and specific business associates, the rules don’t extend to most businesses, according to Glenn Cohen, a professor at Harvard Law School. “Because the average business is not a covered entity or a business associate of a covered entity within the meaning of HIPAA, the statute does not prohibit them asking them about vaccination status,” Cohen said in an email to the VERIFY team. The Centers for Disease Control and Prevention (CDC) on May 13 updated its guidance regarding mask-wearing for people who are fully vaccinated against COVID-19…The question: Is a business asking a customer about their vaccination status a violation of HIPAA? No, most businesses would not violate HIPAA by asking about a customer’s vaccination status…HHS says protected health information under HIPAA includes information that relates to a person’s past, present or future physical or mental health or condition.
What these responses ignore is growing evidence that a third shot may provide lifesaving protection to immunocompromised people (including organ transplant patients), who represent approximately 3% to 4% of our adult population. Some suggest that it’s a cash grab for the vaccine maker and others assert simply that more data are needed. Immunologists, health policy experts, the director of the World Health Organization and pundits have criticized Pfizer for planning to request this approval. scientists met with top Pfizer representatives this week.
Within hours, the Food and Drug Administration and the Centers for Disease Control and Prevention issued a joint statement asserting, “Americans who have been fully vaccinated do not need a booster shot at this time.” The Department of Health and Human Services reiterated this after it and senior U.S. An op-ed by Jennifer Mnookin and Robert Mnookin: Last week, Pfizer announced that it plans to request an emergency use authorization for a booster vaccine shot for COVID-19.
0 kommentar(er)
